Delivery Order SPE2DB22D2206-SPE2DB24FJD24

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $14,887.99 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, to provide Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. This contract is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a $14,041.07 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen, a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,557.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The contract has a performance period through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance...
The Defense Logistics Agency (DLA) awarded a delivery order worth $7,688.41 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The order is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $15,123.75 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Telmisartan-HCTZ 80-25 mg tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to...
This $13,904.88 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Telmisartan-HCTZ 80-25 mg tablet units in packages of 30. This award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX15D1021|SPE2DX24FHQXE) valued at $7,834.79 to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, for the supply of 4564000958 Telmisartan-HCTZ 80-25 mg Tablets in 30-count packages. This delivery order is part of an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp through December 31, 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $11,391.18 to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit doses of 30s. This is an unset-aside firm fixed-price contract with an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corporation, through its Corporate Office Division, is a major supplier of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,845.14 to Amerisourcebergen Drug Corp's Corporate Office Division on June 7, 2024. The contract is for the supply of Telmisartan 80 mg tablets in 30-count packages, with a completion date of June 10, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Telmisartan-HCTZ 40-12.5 mg tablets. The delivery order has a potential value of $3,520.74 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations for this award. This delivery order is issued under an indefinite delivery contract (IDC) that...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJD24
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price Delivery Order contract valued at $5,792.40 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count unit dose packages. This Delivery Order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, which enables the agency to efficiently procure a wide range of pharmaceutical products and medical supplies for the U.S. Armed Forces and other government agencies. The contract does not have a set-aside designation.

Generated 10/10/24, 9:19 AM